Ah, my old buddy Revlon, Inc (NYSE: REV)! Actually, that exclamatory statement is full of sarcasm. Revlon, a beauty-products business whose colleagues include Avon Products, Inc. (NYSE: AVP) and The Estee Lauder Companies Inc. (NYSE: EL), is not a buddy of mine. It is a stock that I really have no intention of buying. The company isn't exactly the most attractive one out there at the moment in terms of fundamentals, but it did have a decent cash-flow statement in the third quarter. Let's check out some numbers.
To begin with, revenues didn't see much growth, as they rose about 1%. Reported net income was $0.57 per diluted share versus a net loss of $0.20 per diluted share in the year-ago period. Unfortunately, that doesn't tell the whole tale. You have to strip out a one-time gain from discontinued operations to get the full story. And you're not going to like it once you do. So, the loss from continuing operations becomes $0.30 per diluted share, which was $0.06 wider than the loss in Q3 2007. Yet, the cash-flow statement does offer a bright spot. Positive operational cash flow of almost $44 million was booked over the last nine months. Last year, Revlon used almost $50 million to fund operations over the nine-month period. Some changes in working capital helped out.
Well, even with the better cash-flow scenario, no, I'm not buying the stock. Revlon is still, in my opinion, a long way off from becoming a great investment idea. I'll need to see more robust growth in the top line and a better profit picture. Sure, for the nine-month period, Revlon did generate a profit of $0.04 per diluted share, but I'm still not convinced. As of this writing, the stock was down 23%. I know it's a bad day in the markets and all, but I wouldn't want to align myself with a company that sees that kind of reaction to earnings. Such a pullback doesn't scream value to me when it comes to Revlon.
Disclosure: I don't own any company mentioned; positions can change at any time.
Estée Lauder Companies (NYSE: EL) is a leading manufacturer and marketer of skin care, makeup, fragrance and hair care products. These are sold in over 140 countries under a variety of established brands, including Estée Lauder, Aramis, Clinique, Bobbi Brown, American Beauty and Grassroots. The firm also operates as a licensee for such fragrance and cosmetic names as Tommy Hilfiger, Kiton, Donna Karan, Daisy Fuentes and Mustang. Estée Lauder sells its products through department stores, specialty retailers, pharmacies and salons, as well as company-owned stores, spas and Web sites. Elizabeth Arden (NASDAQ: RDEN), Procter & Gamble (NYSE: PG) and Revlon (NYSE: REV) are major competitors.
The firm pleased investors earlier in the month, when it reported fiscal Q4 EPS of 61 cents and revenues of $2.01 billion. Analysts had been looking for 56 cents and $1.93 billion. The CEO noted that strategic investments have enabled the company to continue building worldwide share, as it leverages opportunities in emerging markets. Management also guided Q1 EPS to 18-25 cents (24 cent consensus), FY09 EPS to $2.57-$2.72 ($2.66 consensus) and FY09 revenues to about $8.38-$8.54 billion ($8.38B consensus).
Estee Lauder (NYSE: EL), whose colleagues include Avon Products (NYSE: AVP) and Revlon (NYSE: REV), ended the week on a great note. The stock rallied to a new 52-week high of $52.04 on Friday during the intraday session, and closed only several cents below that price at the end of the day. The catalyst for this stellar stock performance can be traced to the beauty company's earnings report, which was released earlier in the week.
According to SmartMoney, Estee Lauder saw top-line growth of 14% during the company's fiscal fourth quarter, with revenues coming in at roughly $2 billion. The bottom line increased 36% to $0.61 per share. Wall Street was only counting on $0.56 per share. So that's a nice $0.05 per share beat. The revenue number also went beyond expectations.
I like the results, and I like that Estee Lauder has been a particularly strong stock. According to the AOL Finance snapshot taken at the time of this writing, the stock has been up for every time frame (1-month, 1-year, etc.). Putting this fact together with the fundamental results of the quarter yields a situation that should be looked at. I don't like that gross margins declined, but I do find the stock appealing considering how bad the market has been.
Avon (NYSE: AVP) delivered not a bag of cosmetics to Wall Street, but a batch of growing earnings. Total revenues for the first quarter were up beautifully, rising 14% to $2.5 billion. Earnings per diluted share likewise did the double-digit-increase dance, rocketing 26% to $0.43.
Now, I would have liked the report a lot more if the company had indicated in its cash flow statement that everything was positive -- unfortunately, that was not to be, as operational cash flow was, in fact, negative. Avon needed to use $41 million for its operating activities during the quarter. Well, one thing I can say is that it's a lot less than the cash needed to fund last year's operations -- Avon burned through over $160 million in the comparable period. A check of the latest 10K shows that, while operational cash flow has been decreasing over the last few years, it has remained positive, so since this is the first quarter of the new fiscal year, we can wait to see how cash flow shapes up as the quarters go by.
Avon competes with companies like Procter & Gamble (NYSE: PG), Revlon (NYSE: REV) and Estee Lauder (NYSE: EL). As I've stated in the past, Procter & Gamble is more my kind of consumer-products business, but I'll give Avon its due since it does have a good product portfolio backing its brand and a devoted base of users. The stock is not too far off from its 52-week high as of this writing, and so long as it can keep sales growing and fight inflationary pressures, it should be a decent long-term bet.
Disclosure: I don't own shares in any of the companies mentioned; positions can change at any time.
Revlon (NYSE: REV) issued a press release concerning its plans for a reverse split as well as some preliminary quarterly results. The reverse split will be based on a 1-for-10 ratio. Well, the company may increase the share price via this method, but it won't make much of a difference in terms of Revlon's potential as an investment.
The stock closed on Friday at $0.99 per share. Let me repeat this -- the stock closed on Friday at $0.99. We are thus talking about a highly speculative equity. Interestingly, if you take a look at the preliminary results, you might believe that Revlon is on the right path. Revlon's management expects a slight dip in terms of net revenues -- the top line will see about $320 million in the quarter versus nearly $329 million in the year-ago period. There will be a net loss of about $5 million this time around versus a net loss of over $35 million last year. Doesn't sound so bad, I suppose, especially when you consider that operating income should come in at $30 million -- that's ten times better than 2007's first quarter. So, would I buy Revlon?
No. I actually owned Revlon stock a few years ago, and I think I essentially broke even when I decided to get the heck out. Revlon has a long way to go before proving to me that it's got a handle on all its problems and that it can get its brand equity back on track. And this reverse stock split means nothing to me, as it doesn't alter the underlying fundamentals. Revlon faces tough competition from other brands, such as Avon (NYSE: AVP), Estee Lauder (NYSE: EL), and products from Procter & Gamble (NYSE: PG), so the company has its work cut out for it.
Disclosure: I don't own shares in any of the companies mentioned here; positions can change at any time.
Here are highlights of some other earnings reports from Thursday:
Gap Inc. (NYSE: GPS) reported a 21% increase in its fourth-quarter profit year over year. The $265 million, or 35 cents per share, matched analysts' expectations. Revenue totaled $4.68 billion, down 5% from the previous year.
Kohls Corp. (NYSE: KSS) fourth-quarter profit fell about 15% year over year to $411.7 million, or $1.31 per share, just beating analysts' estimates. Sales rose less than 1% $5.49 billion, but same-store sales fell.
Novell Inc. (NASDAQ: NOVL) swung to a profit in its fiscal first quarter: $16.8 million, or 5 cents per share, matching expectations. Revenue rose to $230.9 million from $218.4 million a year ago.
As the leveraged buyout market (LBO) tightens amid the backdrop of more expensive debt, deal makers are looking to ride new investment vehicles to make their minions money.
We've seen a surge in popularity in what's called a "Special Purpose Acquisition Company," or SPAC. Bloomberg had a good article this morning on advent of the SPAC and what's happening in the industry as a whole. These companies, also called blank-check companies, are IPO'd after raising their funds. Once public, the founding management team needs to make an acquisition in a given time-frame. Shareholders decide on an individual basis whether they like the deal or not. If they like it, great. If not, they tender their shares and receive their money back.
Essentially, it's a hedged bet on management that their industry expertise will lead to a smart acquisition.
Bloomberg says that since the start of 2003, 144 blank-check companies have sold shares, raising $18.1 billion, with 13 of the deals coming before 2005, according to SPAC Analytics.
Revlon (NYSE: REV) is changing hands at $1.15 in early trading. That's up 10%.
The big rise does not keep the cosmetics company from being one of the most mismanaged public companies going.
In the quarter, revenue grew to $349.2 million from $321.1 million. The company's net loss was $11.3 million, or $0.02 per diluted share, compared to a net loss of $87.1 million, or $0.20 per diluted share.
All of the earnings figures were the good news. The company quoted ACNielsen statistics to show that it market share was down across most of its brands.
Because the company did a bit better than expected, its share are getting a bit of a goose.
Over the last five years, Revlon's share price is down 70%. The shareholders are probably out of sorts, but let them eat lipstick.
This morning Revlon Inc (NYSE: REV) reported their first quarter earnings and the company put up some pretty nice numbers. Revlon matched analyst estimates for the quarter with -$0.07 per share and showed improvements in overall sales as their restructuring plan is moving along as planned.
The company is going to be hosting a conference call starting at 9:30 AM EDT this morning and I am going to be liveblogging the call in its entirety so be sure to refresh your page frequently for up to the minute details on the call.
9:20am- Listening to a little soft music and getting ready for today's call. The call should be getting under way in about 10 minutes.
9:25am- This morning's call should be getting started in about 5 minutes from now. Currently the stock is trading up 4.6% in the premarket. We will periodically check in on the current price through the call and see how traders are reacting to what they are hearing.
9:32am- Still waiting.. seems to be getting a little bit of a late start. Announcer just came on the line to say that the call will start shortly. Stock is trading up 3.1% 3 minutes into the trading session.
9:37am- Finally getting started here. Abby Goldstein going over some compliance issues and getting us started
9:39am- David Kennedy getting us started - going over the numbers: Net revenues of $328 million, up slightly from $325.5 million. Earnings came in at a loss of $35.2 million which as a good improvement from $58.2 million last year first quarter.
Going into today's first quarter announcement, analysts had been expecting to see the company show a quarterly loss of 7 cents per share -- what Revlon wound up with. This is exactly the sort of news the cosmetic giant has been needing lately, and Wall Street is definitely rewarding it in early morning trading. With a little over an hour to go before today's opening bell, the stock has been pushed up 8.4% by pre-market traders.
While we never like to see a company show a loss, Revlon has been in the middle of a restructuring program that does seem to be having a positive effect, and that is what is really going to give traders a reason to buy up the stock today. The company was able to lower its overall costs during the quarter while at the same time increase its overall sales. Compared to the first quarter last year when Revlon showed a loss of $58.2 million, this current quarters loss of $35.2 million is a nice improvement.
Revlon Inc (NYSE: REV) is going to be releasing its first quarter numbers tomorrow morning. Analysts are expecting to see the cosmetic maker post a small loss for the quarter of -$0.07 (edited, originally posted stating est. was -0.01) per share when the numbers are released.
Last week we saw two of Revlon's competitors put up good earnings, so hopefully this is a good indicator that this could be the quarter for Revlon to break out of its recent tough times. On Thursday both Elizabeth Arden (NASDAQ: RDEN) and Lauder (Estee) Co (NYSE: EL) were able to see a nice move up in the market following their recent quarterly numbers.
If Revlon can follow the lead of ARDN and EL, the stock may finally be able to see some upside. REV is currently trading at $1.30 and has been stuck right around this level for the last nine months. The last three quarters Revlon has posted losses and the company could definitely use a dose of positive news to help it break out from its current range.
Last month Revlon added a couple of high-profile celebrities to its list of brand representatives. On April 20th the company announced that it had signed actress Beau Garrett, and then on the 23rd announced that it had added one of the hottest names in Hollywood, Jessica Alba, to the Revlon family. Garrett and Alba join a roster of elite celebrities that includes names such as Halle Berry, Sheryl Crow, and Eva Mendes.
The company will announce its earnings before the market opens tomorrow and will host a conference call starting at 9:30 AM EDT to discuss its quarterly results. We will be liveblogging tomorrow's conference call in its entirety, so join us tomorrow morning for complete coverage of the call.
Michael Fowlkes has worked as a stock trader for seven years and spent the last two years working as an analyst for the online investment advisory service Investor's Observer.
Tough Times for Tarnished American Icons These U.S. companies once dominated competitors and assumed an iconic place in the consumer landscape. But times change. See what's behind their fall and what the future holds for legendary U.S. companies Kodak, Ford, The Gap, Tootsie Roll Industries, New York Times, Revlon, Sara Lee, Harley-Davidson, Winnebago and more. Photo Gallery: Going Cheap: American Icons Tough Times for Tarnished Icons
ETFs vs. Mutual Funds: A Close Race, a Surprising Finish Exchange-traded funds are all the rage these days. New funds are being offered at a rate that outpaces regular mutual funds. Total assets have more than doubled to some $450 billion in less than three years. But do ETFs produce better returns for small investors than regular index funds? A Close Race, a Surprising Finish - WSJ.com
How the Experts Eat If you didn't know sushi should be eaten fish-side down, you may want to check in with these seven experts who share their secrets for properly savoring everything from cheese to chocolate. How the Experts Eat - Portfolio.com
Pick Your Home Improvement Projects Carefully Anyone who has ever owned a home knows that sooner or later you start thinking about ways to make it better. Before launching into any home improvement project you should carefully consider your motivations and goals. Bankrate's interactive guide can help you find the best project based on money, type of project and your skill level. Find a project that fits your home, budget and skill - Bankrate.com Also: 5 Most Popular Projects, 10 Best Resale Projects
Financial Pain Endures for Katrina Victims Financial calamities continue to afflict residents of Louisiana and Mississippi as they struggle to recover from the worst natural disaster in U.S. history. Debt is swelling and credit is suffering as residents deplete savings and take out loans to meet expenses. People of all income levels are affected, but the most desperate are those who had the least before Katrina hit. For Katrina victims, financial pain endures - USATODAY.com
Friday's jobs report showed 111,000 new jobs created and unemployment climbed from 4.5% to 4.6%. These may seem like contradictory numbers, more jobs and more unemployment, but it means more people entered the workforce. There was mildly bullish action in the markets today, with manufactured housing and residential construction up while diversified computer systems and copper weaker. Oil futures rose to $59 a barrel up almost $2.
Movers today included Revlon Inc (NYSE: REV) spiking up $0.18 (13%) to close at $1.49. Rackable Systems (NASDAQ:RACK) was tumbling $3.67 (-18%) to close at $16.69. Active stocks today include Oracle Corp. (NASDAQ:ORCL) up $0.37 (2.1%) to $17.42. Amazon.com Inc. (NASDAQ:AMZN) fell $1.31 (-3.3%) to $37.39 on four times normal volume.
The NYSE had volume of 2.5 billion shares traded with 1,891 issues advancing while 1,359 declined for a small loss of 2.45 points to close at 9,325.24. On the NASDAQ, 1.9 billion shares were traded, 1,645 stocks advanced and 1,360 declined for small gain of 7.50 to 2,475.88.
Companies start to believe their own PR hype. Investors push a stock past logical limits. A company seems about to break down or break out. These are just a few things that can signal a stock with attitude. And... that attitude can be good or bad for the stock price, since attitude always catches up with reality. At least on Wall Street, that is.
Colgate-Palmolive Co. (NYSE:CL) was up $0.71 (1.06%) yesterday to close at $67.42 on about three times its average volume. Investors bid up the stock after a solid earnings report before the open. The technicals for CL have been weakening lately but a continuation of the last two day's advances could change that. The company has an S&P 5 STAR (out of 5) strong buy rating. Out of the 14 other analysts who cover the stock, five give it a strong buy, one a moderate buy, and eight give it a hold. No sell ratings could be a good indicator for CL.